期刊文献+

人促甲状腺激素(hTSH)ELISA的建立 被引量:4

Immunoenzymometric Assay ELISA for Human Thyrotropin
原文传递
导出
摘要 采用抗hTSH单抗8E7包被聚苯乙烯40孔板作为固相抗体,另用高滴度的兔抗hTSH多抗作液相抗体,以辣根过氧化物酶标羊抗兔IgG作为标记第二抗体为反应的显示系统,以邻苯二胺作底物,450nM吸收值计算hTSH浓度,建立了高灵敏度的hTSH酶免吸附测定法(ELISA)。灵敏度为0.03mIU/L。批内CV1.4~6.7%平均5.4%(n=20)批间CV为7.0%。方法特异性鉴定显示与其他糖蛋白激素无明显的交叉反应性。添加回收及稀释度试验鉴定均表明方法重复性、准确性、线性相关都符合临床应用标准。应用本法与瑞士Serono公司出品的酶免磁颗粒分离药盒同时测定130例,相关系数为0.93。 A sensitive and specific ELISA for human thyrotropin was established with strip -wells coated with a monoclonal antibody against h-TSH(8E7), while rabbit anti hTSH antiserum as second antibody. The label was HRP conjugate of goat anti rabbit IgG. In the solid-phase sandwich assay three-step-procedure was used. The assay is specific for h-TSH and no cross reaction with other glyco-proteins, such as h-LH and h-FSH has been observed. The measuring range was 0.15mIU/L ̄150mIU/L; and CV within the assay range was between 1.4% and 6.7%, depending on different doses.Minimum detectable concentration of h-TSH was 0.03mIU/L. A total of samples from 130 were tested. Correlation of the results between this method and TSH Serozyme kit was good (r=0.93). This method for measuring h-TSH in human serum is both convenient and inexpensive.
出处 《上海免疫学杂志》 CSCD 北大核心 1996年第3期149-151,共3页 Shanghai Journal of Immunology
关键词 促甲状腺激素 HTSH ELISA Gaves病 human thyrotropin, immunoenzymometric assay
  • 相关文献

参考文献1

  • 1匿名著者

同被引文献14

  • 1吴晓萍,冯辉,李校堃,苏志坚,郑青,黄亚东.重组人碱性成纤维细胞生长因子突变体[Ser^(69,87)]的表达、纯化及其稳定性研究[J].中国药科大学学报,2005,36(2):168-172. 被引量:2
  • 2滕卫平.对血清促甲状腺激素正常值范围的新认识[J].中华内科杂志,2006,45(2):89-90. 被引量:30
  • 3任凤琴,宋耀虹,冯涛.尿微量白蛋白ELISA测定法最适条件的探讨[J].生物化学与生物物理进展,1997,24(1):88-90. 被引量:1
  • 4Yayon A,Aviezer D,Safran M,et al.Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library[J].Proc Nat Acad Sci USA,1993,90(22):10 643 -10 647.
  • 5Kurokawa M, Doctrow SR, Klagsbrun M. Neutralizing antibodies inhibit the binding of basic fibroblast growth factor to its receptor but not to heparin[J].J Biol Chem,1989,264(13):7 686 -7 691.
  • 6Aonuma M,Yoshitake Y,Nishikawa K.Different antitumor activities of anti-bFGF neutralizing antibodies:heparin-binding domain provides an inefficient epitope for neutralization in vivo[J].Anticancer Res,1999,19(5B):4 039 -4 044.
  • 7Kricka L J.Clinical applications of chemiluminescence[].Analytica Chimica Acta.2003
  • 8Soini JT,Wads ME,Hanninen PE.Detection meth-ods of microsphere based single-step bioaffinity and invitro diagnostics assays[].Journal of Pharmaceutical and Biomedical Analysis.2004
  • 9Phys J,Robent H,Geofferey L.Evaluation of a new strate-gy for dection of thyroid dysfunction in the Roution Laborato-ry[].Clinical Chemistry.1990
  • 10赵利淦,林剑,冯虓.ELISA对样品中微量bFGF的快速定量分析[J].暨南大学学报(自然科学与医学版),1997,18(3):108-109. 被引量:1

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部